•  
  •  
  •  
  •  

2025-10-04 04:51:35

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand

Keywords Selected:  AjantaPharma

Stock Report

  • Ajanta Pharma Ltd consolidated Q1FY26 PAT up at Rs. 255.34 crores
  • Ajanta Pharma Ltd's consolidated profit slips QoQ to Rs. 225.26 crores
  • Ajanta Pharma Ltd's consolidated PAT for Q1 FY2025 jumps to Rs. 245.77 crores
  • Ajanta Pharma Ltd approves buy back of 10,28,881 shares through tender offer
  • Ajanta Pharma Ltd reports Rs. 202.72 crores consolidated PAT in Q4 FY2023-24
  • Ajanta Pharma Ltd posts consolidated Q3FY24 net profit of Rs. 210.03 crores
  • Ajanta Pharma Ltd posts Rs. 195.30 crores consolidated PAT in Q2FY24
  • Ajanta Pharma Ltd receives final approval from US FDA for Topiramate Extended Release Capsules
  • Ajanta Pharma Ltd approves 1st interim dividend of Rs. 25
  • Ajanta Pharma's Q1 FY24 consolidated net profit soars to Rs. 208.12 crores
  • USFDA inspects Ajanta Pharma Ltd's Formulation facility at Dahej
  • Ajanta pharma Ltd reports lower consolidated PAT of Rs. 122.25 crores in Q4FY23
  • Ajanta Pharma announces buyback of equity shares of Rs. 389 crore
  • Ajanta Pharma Ltd consolidated Q3 FY2022-23 net profit falls to Rs. 134.51 crores
  • Ajanta Pharma Ltd consolidated Q2 FY2022-23 net profit lower at Rs. 156.60 crores
  • Ajanta Pharma awarded 'India's Best Managed Companies' by Deloitte
  • Ajanta Pharma Ltd gets Form 483 with 2 procedural observations for Dahej Formulation facility
  • Ajanta Pharma reports rise in Q1FY23 consolidated PAT to Rs. 174.62 crores
  • Ajanta Pharma Ltd allots 4,27,08,385 bonus shares
  • Ajanta Pharma Ltd board approves 1:2 bonus issue
  • Ajanta Pharma consolidated Q4 FY2021-22 net profit lower at Rs. 151.21 crores
  • Ajanta Pharma Ltd board to consider bonus issue on May 10, 2022
  • Ajanta Pharma posts consolidated PAT of Rs. 191.78 crores in Q3 FY22
  • Ajanta Pharma Ltd board approves buyback of shares at Rs. 2550

Latest Post

  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024